Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence

by Andrea Natali, Lorenzo Nesti, Domenico Tricò, Ele Ferrannini
Published 2021-09-01

Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Met...

by Yujin Shin, Ji Hye Moon, Ho Jun Chin, Ele Ferrannini, Soo Lim
Published 2020-06-01

Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients?

by Ele Ferrannini, Stephen J Nicholls, Jørgen Rungby, Jean-Claude Tardif, Faiez Zannad
Published 2015-11-01

Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 Diabetes

by Marta Seghieri, Eleni Rebelos, Andrea Mari, Luigi Sciangula, Carlo Giorda, Ele Ferrannini
Published 2018-08-01

Decreased expression of hepatic glucokinase in type 2 diabetes

by Rebecca A. Haeusler, Stefania Camastra, Brenno Astiarraga, Monica Nannipieri, Marco Anselmino, Ele Ferrannini
Published 2015-03-01

Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.

by Andrea Mari, Jonatan I Bagger, Ele Ferrannini, Jens J Holst, Filip K Knop, Tina Vilsbøll
Published 2013-01-01

Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk.

by Kirstine J Belongie, Ele Ferrannini, Kjell Johnson, Patricia Andrade-Gordon, Michael K Hansen, John R Petrie
Published 2017-01-01

Sweetened beverages intake, hyperuricemia and metabolic syndrome. The Mexico City Diabetes Study.

by Rubén López-Molina, Socorro Parra-Cabrera, Ruy López-Ridaura, María E González-Villalpando, Ele Ferrannini, Clicerio González-Villalpando
Published 2013-11-01

Insulin enhances renal glucose excretion: relation to insulin sensitivity and sodium-glucose cotransport

by Ele Ferrannini, Ricardo Pereira-Moreira, Marta Seghieri, Eleni Rebelos, Aglécio L Souza, Valeria B Chueire, Caterina Arvia, Elza Muscelli
Published 2020-04-01

Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery

by Giuseppe Daniele, Beatrice Campi, Alessandro Saba, Alessandro Saba, Simone Codini, Annamaria Ciccarone, Laura Giusti, Stefano Del Prato, Russel L. Esterline, Ele Ferrannini
Published 2020-04-01

Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery

by Stefania Camastra, Alessandra Vitali, Marco Anselmino, Amalia Gastaldelli, Rosario Bellini, Rossana Berta, Ilenia Severi, Simona Baldi, Brenno Astiarraga, Giorgio Barbatelli, Saverio Cinti, Ele Ferrannini
Published 2017-08-01

Elevated Plasma Levels of 3-Hydroxyisobutyric Acid Are Associated With Incident Type 2 Diabetes

by Adil Mardinoglu, Silvia Gogg, Luca A. Lotta, Alena Stančáková, Annika Nerstedt, Jan Boren, Matthias Blüher, Ele Ferrannini, Claudia Langenberg, Nicholas J. Wareham, Markku Laakso, Ulf Smith
Published 2018-01-01

Brain substrate metabolism and ß‐cell function in humans: A positron emission tomography study

by Eleni Rebelos, Andrea Mari, Marco Bucci, Miikka‐Juhani Honka, Jarna C. Hannukainen, Kirsi A. Virtanen, Jussi Hirvonen, Lauri Nummenmaa, Martin Heni, Patricia Iozzo, Ele Ferrannini, Pirjo Nuutila
Published 2020-07-01

alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population.

by Walter E Gall, Kirk Beebe, Kay A Lawton, Klaus-Peter Adam, Matthew W Mitchell, Pamela J Nakhle, John A Ryals, Michael V Milburn, Monica Nannipieri, Stefania Camastra, Andrea Natali, Ele Ferrannini, RISC Study Group
Published 2010-05-01